​​​​​​​Stellenbosch University Immunology Research Group

Publications

2011

​1. The influence of different helminth infection phenotypes on immune responses against HIV in co-infected adults in South Africa.

Mkhize-Kwitshana ZL, Taylor M, Jooste P, Mabaso ML, Walzl G. BMC Infect Dis. 2011 Oct 14;11:273. doi: 10.1186/1471-2334-11-273

http://www.biomedcentral.com/1471-2334/11/273

2. Medroxyprogesterone acetate alters Mycobacterium bovis BCG-induced cytokine production in peripheral blood mononuclear cells of contraceptive users.

Kleynhans L, Du Plessis N, Black GF, Loxton AG, Kidd M, van Helden PD, Walzl G, Ronacher K. PLoS One. 2011;6(9):e24639

 http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0024639

3. Molecular bacterial load assay, a culture-free biomarker for rapid and accurate quantification of sputum Mycobacterium tuberculosis bacillary load during treatment.

Honeyborne I, McHugh TD, Phillips PP, Bannoo S, Bateson A, Carroll N, Perrin FM, Ronacher K, Wright L, van Helden PD, Walzl G, Gillespie SH. J Clin Microbiol. 2011 Nov;49(11):3905

 http://jcm.asm.org/content/early/2011/09/07/JCM.00547-11

4. Predominance of interleukin-22 over interleukin-17 at the site of disease in human tuberculosis.

Matthews K, Wilkinson KA, Kalsdorf B, Roberts T, Diacon A, Walzl G, Wolske J, Ntsekhe M, Syed F, Russell J, Mayosi BM, Dawson R, Dheda K, Wilkinson RJ, Hanekom WA, Scriba TJ. Tuberculosis (Edinb). 2011 Nov;91(6):587-93

http://www.ncbi.nlm.nih.gov/pubmed/21767990

5. Tuberculosis assays: past, present and future.

Chegou NN, Hoek KG, Kriel M, Warren RM, Victor TC, Walzl G. Expert Rev Anti Infect Ther. 2011 Apr;9(4):457-69

http://www.ncbi.nlm.nih.gov/pubmed/21504402

6. Immunological biomarkers of tuberculosis.

Walzl G, Ronacher K, Hanekom W, Scriba TJ, Zumla A. Nat Rev Immunol. 2011 May;11(5):343-54

http://www.ncbi.nlm.nih.gov/pubmed/21475309

7. The effect of vitamin A and zinc supplementation on treatment outcomes in pulmonary tuberculosis: a randomized controlled trial.

Visser ME, Grewal HM, Swart EC, Dhansay MA, Walzl G, Swanevelder S, Lombard C, Maartens G. Am J Clin Nutr. 2011 Jan;93(1):93-100

http://www.ncbi.nlm.nih.gov/pubmed/21068353

8. Human gene expression profiles of susceptibility and resistance in tuberculosis.

Maertzdorf J, Repsilber D, Parida SK, Stanley K, Roberts T, Black G, Walzl G, Kaufmann SH. Genes Immun. 2011 Jan;12(1):15-22

http://www.ncbi.nlm.nih.gov/pubmed/20861863

9. Hypercytokinaemia accompanies HIV-tuberculosis immune reconstitution inflammatory syndrome.

Tadokera R, Meintjes G, Skolimowska KH, Wilkinson KA, Matthews K, Seldon R, Chegou NN, Maartens G, Rangaka MX, Rebe K, Walzl G, Wilkinson RJ. Eur Respir J. 2011 May;37(5):1248-59

http://www.ncbi.nlm.nih.gov/pubmed/20817712

10. Suppressor of cytokine signaling-3 is affected in T-cells from tuberculosisTB patients.

Jacobsen M, Repsilber D, Kleinsteuber K, Gutschmidt A, Schommer-Leitner S, Black G, Walzl G, Kaufmann SH. Clin Microbiol Infect. 2011 Sep;17(9):1323-31

http://www.ncbi.nlm.nih.gov/pubmed/20673263​